WO2026064643A1 - Composés, compositions et leurs procédés d'utilisation - Google Patents

Composés, compositions et leurs procédés d'utilisation

Info

Publication number
WO2026064643A1
WO2026064643A1 PCT/US2025/047207 US2025047207W WO2026064643A1 WO 2026064643 A1 WO2026064643 A1 WO 2026064643A1 US 2025047207 W US2025047207 W US 2025047207W WO 2026064643 A1 WO2026064643 A1 WO 2026064643A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
compound
cycloalkyl
aryl
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2025/047207
Other languages
English (en)
Inventor
Jean-Francois BRAZEAU
Pengyu YANG
Kyohei Hayashi
Kevin Freeman-Cook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plexium Inc
Original Assignee
Plexium Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plexium Inc filed Critical Plexium Inc
Publication of WO2026064643A1 publication Critical patent/WO2026064643A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des composés qui se lient à et/ou dégradent une ou plusieurs kinases dépendantes de la cycline, ainsi que des compositions pharmaceutiques comprenant les composés de l'invention, et des méthodes de traitement de maladies, de troubles et d'états médiés, au moins en partie, par des kinases dépendantes de la cycline.
PCT/US2025/047207 2024-09-20 2025-09-19 Composés, compositions et leurs procédés d'utilisation Pending WO2026064643A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202463697347P 2024-09-20 2024-09-20
US63/697,347 2024-09-20

Publications (1)

Publication Number Publication Date
WO2026064643A1 true WO2026064643A1 (fr) 2026-03-26

Family

ID=99168791

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2025/047207 Pending WO2026064643A1 (fr) 2024-09-20 2025-09-19 Composés, compositions et leurs procédés d'utilisation

Country Status (1)

Country Link
WO (1) WO2026064643A1 (fr)

Similar Documents

Publication Publication Date Title
JP7675777B2 (ja) 免疫調節剤としての複素環式化合物
US11760756B2 (en) Crystalline form of a PD-1/PD-L1 inhibitor
US11753406B2 (en) Salts of a PD-1/PD-L1 inhibitor
US20240132523A1 (en) Salts and crystalline forms of a pd-1/pd-l1 inhibitor
US10329255B2 (en) Salts of an LSD1 inhibitor
US20180057486A1 (en) Heterocyclic compounds as immunomodulators
JP2023533982A (ja) Gas41阻害剤及びその使用方法
WO2026064643A1 (fr) Composés, compositions et leurs procédés d'utilisation
HK40097413A (en) Heterocyclic compounds as immunomodulators
HK40097413B (en) Heterocyclic compounds as immunomodulators
HK40047182B (en) Heterocyclic compounds as immunomodulators
HK40047182A (en) Heterocyclic compounds as immunomodulators
WO2023019430A1 (fr) Composés à utiliser en tant qu'immunomodulateurs d'interactions pd-l1
HK40009864A (en) Heterocyclic compounds as immunomodulators
HK40009864B (en) Heterocyclic compounds as immunomodulators
HK40014224B (en) Pyridine derivatives as immunomodulators
HK40014224A (en) Pyridine derivatives as immunomodulators